From: In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria
Organism | Mul-1867 (mg/L) | CHG (mg/L) | ||
---|---|---|---|---|
MIC | MBC | MIC | MBC | |
Gram-positive bacteria | ||||
B. cereus VT-289 | 0.5 | 2 | 1.0 | 2.0 |
E. faecalis ATCC 29212 | 0.03 | 0.06 | 2.0 | 8.0 |
E. faecalis VT-72 | 0.06 | 0.125 | 4.0 | 16.0 |
E. faecalis VT-693 | 0.06 | 0.06 | 2.0 | 16.0 |
S. aureus АТСС 29213 | 0.125 | 0.15 | 2.0 | 2.0 |
S. аureus MSSA VT-961 | 0.06 | 0.125 | 2.0 | 2.0 |
S. aureus MRSA VT-234 | 0.06 | 0.125 | 4.0 | 4.0 |
S. epidermidis VT-432 | 0.06 | 0.125 | 2.0 | 16.0 |
S. epidermidis VT 908 | 0.25 | 0.5 | 2.0 | 16.0 |
S. mitis VT-842 | 0.06 | 0.06 | 4.0 | 64.0 |
S. pyogenes VT 59 | 0.125 | 0.125 | 8.0 | 16.0 |
Gram-negative bacteria | ᅟ | ᅟ | ᅟ | ᅟ |
E. coli АТСС 25922 | 0.25 | 0.25 | 2.0 | 16.0 |
E. coli VT-1402 | 0.06 | 0.06 | 16.0 | 32.0 |
K. pneumoniae VT-1367 | 0.125 | 0.25 | 32.0 | 32.0 |
N. subflava VT-455 | 0.125 | 0.25 | 8.0 | 8.0 |
P. aeruginosae ATCC 27853 | 1.0 | 1.0 | 32.0 | 64.0 |
P. aeruginosae VT-177 | 0.125 | 0.25 | 32.0 | 32.0 |
S. enterica VT-191 | 0.5 | 2 | 16.0 | 32.0 |